D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ACRV holding history
Acrivon Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACRV overviewAll 13F holders of ACRVFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −31,939−100.0% | Sold out | Holders |
| Q4 2023 | 31,939 | $157.1K | <0.1% | −14,811−31.7% | Reduced | Holders |
| Q3 2023 | 46,750 | $446.9K | <0.1% | −160−0.3% | Reduced | Holders |
| Q2 2023 | 46,910 | $608.0K | <0.1% | −14,986−24.2% | Reduced | Holders |
| Q1 2023 | 61,896 | $785.5K | <0.1% | +61,896 | New | Holders |